Symmetry Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.84M | Buy |
14,297
+1,303
| +10% | +$153K | 0.09% | 65 |
|
|
2026
Q1 | $1.56M | Buy |
12,994
+185
| +1% | +$21.4K | 0.09% | 63 |
|
|
2025
Q4 | $1.35M | Buy |
12,809
+9,406
| +276% | +$883K | 0.08% | 64 |
|
|
2025
Q3 | $286K | Buy |
+3,403
| New | +$280K | 0.03% | 125 |
|
|
2025
Q2 | – | Sell |
-2,579
| Closed | -$232K | – | 153 |
|
|
2025
Q1 | $232K | Buy |
2,579
+172
| +7% | +$16.1K | 0.03% | 119 |
|
|
2024
Q4 | $239K | Sell |
2,407
-1,513
| -39% | -$156K | 0.03% | 116 |
|
|
2024
Q3 | $445K | Sell |
3,920
-7,866
| -67% | -$935K | 0.11% | 62 |
|
|
2024
Q2 | $1.46M | Sell |
11,786
-968
| -8% | -$125K | 0.08% | 116 |
|
|
2024
Q1 | $1.68M | Sell |
12,754
-13,754
| -52% | -$1.7M | 0.13% | 104 |
|
|
2023
Q4 | $2.88M | Sell |
26,508
-42,084
| -61% | -$4.37M | 0.16% | 65 |
|
|
2023
Q3 | $7.06M | Sell |
68,592
-13,143
| -16% | -$1.42M | 0.38% | 54 |
|
|
2023
Q2 | $9.43M | Sell |
81,735
-433
| -0.5% | -$49.2K | 0.5% | 46 |
|
|
2023
Q1 | $8.74M | Buy |
82,168
+6,969
| +9% | +$752K | 0.48% | 46 |
|
|
2022
Q4 | $8.34M | Buy |
75,199
+4,787
| +7% | +$489K | 0.49% | 43 |
|
|
2022
Q3 | $6.06M | Sell |
70,412
-45
| -0.1% | -$4.02K | 0.41% | 45 |
|
|
2022
Q2 | $6.42M | Buy |
70,457
+57,601
| +448% | +$5.11M | 0.43% | 40 |
|
|
2022
Q1 | $1.05M | Buy |
12,856
+3,129
| +32% | +$247K | 0.07% | 185 |
|
|
2021
Q4 | $745K | Sell |
9,727
-2,454
| -20% | -$195K | 0.05% | 290 |
|
|
2021
Q3 | $994K | Hold |
12,181
| – | – | 0.07% | 219 |
|
|
2021
Q2 | $947K | Sell |
12,181
-456
| -4% | -$33.9K | 0.06% | 244 |
|
|
2021
Q1 | $930K | Sell |
12,637
-21,324
| -63% | -$1.57M | 0.07% | 216 |
|
|
2020
Q4 | $2.65M | Sell |
33,961
-1,144
| -3% | -$87.5K | 0.21% | 73 |
|
|
2020
Q3 | $2.78M | Buy |
35,105
+19,766
| +129% | +$1.55M | 0.24% | 66 |
|
|
2020
Q2 | $1.13M | Buy |
+15,339
| New | +$1.15M | 0.14% | 72 |
|
|
2020
Q1 | – | Sell |
-24,569
| Closed | -$2.13M | – | 330 |
|
|
2019
Q4 | $2.13M | Sell |
24,569
-10,542
| -30% | -$866K | 0.44% | 36 |
|
|
2019
Q3 | $2.82M | Hold |
35,111
| – | – | 0.58% | 30 |
|
|
2019
Q2 | $2.81M | Sell |
35,111
-1,268
| -3% | -$97.1K | 0.57% | 33 |
|
|
2019
Q1 | $2.89M | Buy |
36,379
+15,576
| +75% | +$1.16M | 0.49% | 30 |
|
|
2018
Q4 | $1.52M | Buy |
+20,803
| New | +$1.47M | 0.39% | 39 |
|
Other funds holding MRK
Symmetry Partners's MRK Position: Q2 2026 in Review
Symmetry Partners increased its Merck (MRK) stake by 10% in Q2 2026, buying an estimated $153K and bringing the position to 14,297 shares worth $1.84M. The position accounts for 0.09% of the portfolio, ranked #65.
Symmetry Partners first reported a position in MRK in Q4 2018 and has held it in 29 quarters since. The position peaked at $9.43M in Q2 2023. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Symmetry Partners held 14,297 shares of Merck worth $1.84M as of Q2 2026.
- Symmetry Partners bought 1,303 Merck shares in Q2 2026, an estimated $153K.
- Merck made up 0.09% of Symmetry Partners's portfolio in Q2 2026, its #65 holding.
- Symmetry Partners first reported a position in Merck in Q4 2018 and has held it in 29 quarters since.
- Symmetry Partners's Merck position peaked at $9.43M in Q2 2023.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.